Global Batten Disease Treatment Market by Disease Type and Therapy Type - Forecast to 2023 - ResearchAndMarkets.com

November 30, 2018

DUBLIN--(BUSINESS WIRE)--Nov 30, 2018--The “Batten Disease Treatment Market by Disease Type and by Therapy Type includes Occupational Therapy and Physical Therapy: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023” report has been added to ResearchAndMarkets.com’s offering.

The report covers forecast and analysis for the Batten disease treatment market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Million).

The study includes drivers and restraints for the Batten disease treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Batten disease treatment market on a global level.

In order to give the users of this report a comprehensive view on the Batten disease treatment market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis. Wherein test type segments and therapy segments are benchmarked based on their market size, growth, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the players in the market. In addition, the report also covers key strategic developments of the market including acquisitions and mergers, new technology launch, agreements, partnerships collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, disease portfolio of various companies according to the region.

The study provides a decisive view on the Batten disease treatment market by segmenting the market based on disease type and therapy type and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2023.

Based on disease market is segmented into Infantile NCL, Late Infantile NCL, Juvenile NCL, and Adult NCL. Therapy type covered in this report includes occupational and physical therapies.

Key Topics Covered

1. Introduction

1.1. Report description and scope

1.2. Research scope

1.3. Research methodology

1.3.1. Market research process

1.3.2. Market research methodology

2. Executive Summary

2.1. Global Batten Disease Treatment market, 2017 - 2023 (USD Million)

2.2. Global Batten Disease Treatment market: Snapshot

3. Batten Disease Treatment - Market Dynamics

3.1. Introduction

3.2. Market drivers

3.2.1. Global Batten Disease Treatment market drivers: Impact analysis

3.2.2. Increase in the prevalence of Batten disease

3.2.3. Increase in research and development

3.3. Market Restraints

3.3.1. Global Batten Disease Treatment market restraints: Impact analysis

3.3.2. Lack of awareness

3.4. Opportunities

3.4.1. Drug Discovery and Drug launch

3.5. Porters five forces analysis

3.6. Market attractiveness analysis

4. Global Batten Disease Treatment Market - Competitive Landscape

4.1. Company Market Share Analysis

4.2. Strategic Development

4.3. Price Trend Analysis

4.4. Technology Portfolio

5. Global Batten Disease Treatment Market -Disease Type Segment Analysis

5.1. Global Batten Disease Treatment market: Disease Type overview

5.2. Infantile NCL

6. Global Infantile NCL Treatment market, 2017 - 2023(USD Million)

6.1. Late Infantile NCL

6.2. Juvenile NCL

6.3. Adult NCL

7. Global Batten Disease Treatment Market - Therapy Segment Analysis

7.1. Global Batten Disease Treatment market: Therapy overview

7.2. Occupational therapy

7.3. Physical Therapy

8. Global Batten Disease Treatment Market - Regional Segment Analysis

8.1. Global Batten Disease Treatment market: Regional overview

8.2. North America

8.3. Europe

8.4. Asia Pacific

8.5. Latin America

8.6. Middle East and Africa

9. Company Profile

9.1. ReGenX Biosciences LLC

9.2. BioMarin Pharmaceuticals

9.3. SenebBioSciences Inc.

For more information about this report visit https://www.researchandmarkets.com/research/67qdst/global_batten?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181130005414/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Clinical Therapies,Endocrine and Metabolic Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/30/2018 12:59 PM/DISC: 11/30/2018 12:59 PM


Update hourly